Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Prostate Cancer

Free Subscription Articles published in JAMA Retrieve available abstracts of 17 articles: HTML format

Single Articles

July 2024
1. NIK-AHD F, De Hoedt AM, Butler C, Anger JT, et al
   Prostate-Specific Antigen Values in Transgender Women Receiving Estrogen.
   JAMA. 2024;332:335-337.
   PubMed    
   
   
   June 2024
2. FENG X, Zahed H, Onwuka J, Callister MEJ, et al
   Cancer Stage Compared With Mortality as End Points in Randomized Clinical Trials of Cancer Screening: A Systematic Review and Meta-Analysis.
   JAMA. 2024;331:1910-1917.
   PubMed     Abstract available
   
   
   May 2024
3. NEWCOMB LF, Schenk JM, Zheng Y, Liu M, et al
   Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate Cancer.
   JAMA. 2024 May 30. doi: 10.1001/jama.2024.6695.
   PubMed     Abstract available
   
   
   
4. HARRIS E
   Urine-Based Test Could Help Identify Aggressive Prostate Cancer.
   JAMA. 2024 May 17. doi: 10.1001/jama.2024.8424.
   PubMed    
   
   
   
5. HARRIS E
   Prostate Cancer Cases Might Rise to 3 Million Globally by 2040.
   JAMA. 2024 May 3. doi: 10.1001/jama.2024.6729.
   PubMed    
   
   
   April 2024
6. BAROCAS DA, Al Hussein Al Awamlh B, Koyama T
   Outcomes Following Localized Prostate Cancer Treatment-Reply.
   JAMA. 2024 Apr 29. doi: 10.1001/jama.2024.5492.
   PubMed    
   
   
   
7. HUANG TB, Ding XF
   Outcomes Following Localized Prostate Cancer Treatment.
   JAMA. 2024 Apr 29. doi: 10.1001/jama.2024.5486.
   PubMed    
   
   
   
8. CORNU JN
   Outcomes Following Localized Prostate Cancer Treatment.
   JAMA. 2024 Apr 29. doi: 10.1001/jama.2024.5489.
   PubMed    
   
   
   
9. AUVINEN A, Tammela TLJ, Mirtti T, Lilja H, et al
   Prostate Cancer Screening With PSA, Kallikrein Panel, and MRI: The ProScreen Randomized Trial.
   JAMA. 2024 Apr 6:e243841. doi: 10.1001/jama.2024.3841.
   PubMed     Abstract available
   
   
   
10. TOSOIAN JJ, Penson DF, Chinnaiyan AM
    A Pragmatic Approach to Prostate Cancer Screening.
    JAMA. 2024 Apr 6. doi: 10.1001/jama.2024.4089.
    PubMed    
    
    
    
11. MARTIN RM, Turner EL, Young GJ, Metcalfe C, et al
    Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical Trial.
    JAMA. 2024 Apr 6:e244011. doi: 10.1001/jama.2024.4011.
    PubMed     Abstract available
    
    
    January 2024
12. AL HUSSEIN AL AWAMLH B, Wallis CJD, Penson DF, Huang LC, et al
    Functional Outcomes After Localized Prostate Cancer Treatment.
    JAMA. 2024;331:302-317.
    PubMed     Abstract available
    
    
    April 2023
13. NIK-AHD F, De Hoedt A, Butler C, Anger JT, et al
    Prostate Cancer in Transgender Women in the Veterans Affairs Health System, 2000-2022.
    JAMA. 2023 Apr 29:e236028. doi: 10.1001/jama.2023.6028.
    PubMed    
    
    
    March 2023
14. HARRIS E
    Treatment Type Did Not Change Prostate Cancer Survival in UK Trial.
    JAMA. 2023 Mar 22. doi: 10.1001/jama.2023.4002.
    PubMed    
    
    
    May 2022
15. LARKIN HD
    Targeted Radioligand Approved for Metastatic Prostate Cancer.
    JAMA. 2022;327:1642.
    PubMed    
    
    
    January 2022
16. SLOMSKI A
    Some Men With Localized Prostate Cancer Regret Surgery.
    JAMA. 2022;327:26.
    PubMed    
    
    
    November 2021
17. SLOMSKI A
    High-Intensity Interval Training in Prostate Cancer.
    JAMA. 2021;326:1666.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.